Cannabis Freedom Index
← History

Medical 🇹🇷 Türkiye

Türkiye sets product-by-product rules for cannabis pharmacy sales

Implementing rules require individual authorisation before cannabis-derived medicinal products can be marketed, with separate requirements for health, support and cosmetic products. The pharmacy-sale framework follows the 2025 enabling law; it does not itself show that a product has been dispensed.[1]

Listed for context. No score change is recorded for Türkiye here.

References

  1. Regulation on Products Derived from Hemp, Official Gazette 33154, 31 January 2026Articles 5 and 24 and pharmacy-sale rules.archived

Checked. The date and the event were compared with a source that was read.

    ↑↓ to move, ↵ to open.